BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3418389)

  • 1. Effects of treatment with U-74006F on neurological outcome following experimental spinal cord injury.
    Anderson DK; Braughler JM; Hall ED; Waters TR; McCall JM; Means ED
    J Neurosurg; 1988 Oct; 69(4):562-7. PubMed ID: 3418389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delayed administration of U74006F (tirilazad mesylate) on recovery of locomotor function after experimental spinal cord injury.
    Anderson DK; Hall ED; Braughler JM; McCall JM; Means ED
    J Neurotrauma; 1991; 8(3):187-92. PubMed ID: 1803027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673.
    Behrmann DL; Bresnahan JC; Beattie MS
    Exp Neurol; 1994 Mar; 126(1):61-75. PubMed ID: 8157127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an intensive methylprednisolone sodium succinate dosing regimen in experimental spinal cord injury.
    Braughler JM; Hall ED; Means ED; Waters TR; Anderson DK
    J Neurosurg; 1987 Jul; 67(1):102-5. PubMed ID: 3598657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats.
    Hall ED
    J Neurosurg; 1988 Mar; 68(3):462-5. PubMed ID: 3343617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against postischemic spinal cord injury using a new 21-aminosteroid.
    Fowl RJ; Patterson RB; Gewirtz RJ; Anderson DK
    J Surg Res; 1990 Jun; 48(6):597-600. PubMed ID: 2362420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism.
    Hall ED; Yonkers PA; Horan KL; Braughler JM
    J Neurotrauma; 1989; 6(3):169-76. PubMed ID: 2810381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 21-aminosteroid (U-74006F) on cerebral metabolites and edema after severe experimental head trauma.
    Dimlich RV; Tornheim PA; Kindel RM; Hall ED; Braughler JM; McCall JM
    Adv Neurol; 1990; 52():365-75. PubMed ID: 2396533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tirilazad mesylate (U-74006F) and methylprednisolone sodium succinate treatments in experimental allergic encephalomyelitis in the guinea pig.
    Karlik SJ; Stavraky RT; Hall ED
    Mult Scler; 1996 Feb; 1(4):228-35. PubMed ID: 9345440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury.
    Hall ED; Yonkers PA; Andrus PK; Cox JW; Anderson DK
    J Neurotrauma; 1992 May; 9 Suppl 2():S425-42. PubMed ID: 1613805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
    Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
    Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis.
    Hall ED; Wolf DL; Braughler JM
    J Neurosurg; 1984 Jul; 61(1):124-30. PubMed ID: 6374068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia.
    Park CK; Hall ED
    Brain Res; 1994 May; 645(1-2):157-63. PubMed ID: 8062078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of ischemia-reperfusion injury in skeletal muscle: efficacy of 21-aminosteroids on microcirculation and muscle contraction after an extended period of warm ischemia.
    Korompilias AV; Chen LE; Seaber AV; Urbaniak JR
    J Orthop Res; 1997 Jul; 15(4):512-8. PubMed ID: 9379260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism.
    Braughler JM; Hall ED
    J Neurosurg; 1984 Aug; 61(2):290-5. PubMed ID: 6539814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils.
    Hall ED; Pazara KE; Braughler JM
    Stroke; 1991 Mar; 22(3):361-6. PubMed ID: 2003306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of tirilazad mesylate (U-74006F), mannitol, and their combination on experimental ischemia.
    Oktem IS; Menkü A; Akdemir H; Kontaş O; Kurtsoy A; Koç RK
    Res Exp Med (Berl); 2000 Feb; 199(4):231-42. PubMed ID: 10743681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage.
    Francel PC; Long BA; Malik JM; Tribble C; Jane JA; Kron IL
    J Neurosurg; 1993 Nov; 79(5):742-51. PubMed ID: 8410254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental spinal cord injury: treatment with naloxone.
    Flamm ES; Young W; Demopoulos HB; DeCrescito V; Tomasula JJ
    Neurosurgery; 1982 Feb; 10(2):227-31. PubMed ID: 7070619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant therapy in experimental spinal cord injury.
    Anderson DK
    Restor Neurol Neurosci; 1991 Jan; 2(4):169-74. PubMed ID: 21551600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.